Author Response: Identification of a GABAergic Neural Circuit Governing Leptin Signaling Deficiency-Induced Obesity
Yong Han,Yang He,Lauren Harris,Yong Xu,Qi Wu
DOI: https://doi.org/10.7554/elife.82649.sa2
2022-01-01
Abstract:Article Figures and data Abstract Editor's evaluation Introduction Results Discussion Materials and methods Data availability References Decision letter Author response Article and author information Metrics Abstract The hormone leptin is known to robustly suppress food intake by acting upon the leptin receptor (LepR) signaling system residing within the agouti-related protein (AgRP) neurons of the hypothalamus. However, clinical studies indicate that leptin is undesirable as a therapeutic regiment for obesity, which is at least partly attributed to the poorly understood complex secondary structure and key signaling mechanism of the leptin-responsive neural circuit. Here, we show that the LepR-expressing portal neurons send GABAergic projections to a cohort of α3-GABAA receptor expressing neurons within the dorsomedial hypothalamic nucleus (DMH) for the control of leptin-mediated obesity phenotype. We identified the DMH as a key brain region that contributes to the regulation of leptin-mediated feeding. Acute activation of the GABAergic AgRP-DMH circuit promoted food intake and glucose intolerance, while activation of post-synaptic MC4R neurons in the DMH elicited exactly opposite phenotypes. Rapid deletion of LepR from AgRP neurons caused an obesity phenotype which can be rescued by blockage of GABAA receptor in the DMH. Consistent with behavioral results, these DMH neurons displayed suppressed neural activities in response to hunger or hyperglycemia. Furthermore, we identified that α3-GABAA receptor signaling within the DMH exerts potent bi-directional regulation of the central effects of leptin on feeding and body weight. Together, our results demonstrate a novel GABAergic neural circuit governing leptin-mediated feeding and energy balance via a unique α3-GABAA signaling within the secondary leptin-responsive neural circuit, constituting a new avenue for therapeutic interventions in the treatment of obesity and associated comorbidities. Editor's evaluation Leptin is a fat-derived hormone that curbs appetite, and mutation of leptin causes obesity and diabetes. This manuscript investigates leptin-responsive neural circuits, revealing a key inhibitory connection from leptin-sensitive neurons in the arcuate nucleus of the hypothalamus (AGRP neurons) to neurons in the dorsomedial hypothalamus. Toggling this inhibitory connection impacted leptin effects on feeding and metabolism. https://doi.org/10.7554/eLife.82649.sa0 Decision letter Reviews on Sciety eLife's review process Introduction Diet-induced obesity (DIO) drastically increases susceptibility to the development of metabolic, cardiovascular, and neurological diseases, as well as the recent coronavirus disease (Kahn et al., 2006; Ren et al., 2021; Clemmensen et al., 2020; Xia et al., 2021; Benito-León et al., 2013). Leptin, a hormone secreted by white adipocytes, interacts with receptors in the brain to communicate peripheral fuel status, suppress appetite following a meal, promote energy expenditure, and maintain blood glucose stability (Friedman, 2009; Friedman, 2014; Flak and Myers, 2016; Friedman, 2019; Knight et al., 2010; Berglund et al., 2012; Caron et al., 2018). One of the key pathological characteristics of DIO is impaired metabolic homeostasis (Considine et al., 1995; Maffei et al., 1995). There is much evidence that central leptin signaling plays a vital role in the regulation of body weight, primarily via action within the arcuate nucleus (ARC)(Friedman, 2014; Flak and Myers, 2016; Minokoshi et al., 2002; Huynh et al., 2010; Pereira et al., 2019; Xu et al., 2018; Varela and Horvath, 2012; Vong et al., 2011). The long-form leptin receptors are abundantly expressed in the agouti-related protein (AgRP) neurons of the ARC (Xu et al., 2018; Baskin et al., 1999; Xu and Xie, 2016; Scott et al., 2009; Scott et al., 2011). Previous studies demonstrate that, under the physiological condition, leptin directly inhibits leptin receptor (LepR)-expressing AgRP neurons (Cowley et al., 2001; van den Top et al., 2004). However, clinical studies suggest that treatment of leptin in common obese patients has limited efficacy (Heymsfield et al., 1999; Farr et al., 2015; Hinney et al., 2022). The neural-circuit and transmitter-signaling mechanisms underlying leptin-mediated control of body weight and energy balance are not established. AgRP neurons play fundamental roles in regulating feeding behavior and body weight by releasing inhibitory neuropeptide Y (NPY), AgRP and GABA transmitters into many downstream brain areas (Kishi and Elmquist, 2005; Han et al., 2021b; Xia et al., 2021). The afferents to these AgRP neurons and their postsynaptic targets have been identified as key players in the regulation of energy balance and systemic insulin sensitivity (Myers et al., 2009; Gropp et al., 2005; Luquet et al., 2005; Aponte et al., 2011; Könner et al., 2007; Steculorum et al., 2016). Leptin acts to decrease food intake and promote energy expenditure by suppressing the activity of AgRP neurons (Cowley et al., 2001; van den Top et al., 2004; Halaas et al., 1997; Friedman and Halaas, 1998). Selective ablation of LepR in AgRP neurons gives rise to an obese phenotype and diabetes (Xu et al., 2018; van de Wall et al., 2008). Although the LepR signaling within AgRP neurons has been implicated as the dominant component for the regulation of metabolic homeostasis, the underlying neural circuit mechanism is still poorly understood. We hypothesize that identification of the critical transmitter signaling components underlying the leptin-responsive neural circuit is crucial for the development of more efficient therapeutics for obesity. Emerging data suggest a critical role of GABA signaling on the control of feeding behavior and energy homeostasis (Vong et al., 2011; Cone, 2005; Meister, 2007; Morton et al., 2006; Saper et al., 2002; Wu and Palmiter, 2011; Liu et al., 2012; Wu et al., 2013; Wu et al., 2009; Wu et al., 2012; Rossi and Stuber, 2018; Richard, 2015; Meng et al., 2016; Garfield et al., 2016; Pool et al., 2014; Cai et al., 2014; Krashes et al., 2013). Numerous studies suggest that central GABAA- and GABAB-receptor signaling exert prominent influences on feeding behavior under various metabolic states (Berridge, 2009; Cooper, 2005; Duke et al., 2006; Martire et al., 2010; Peciña and Berridge, 1996; Strader et al., 1997; Berner et al., 2009). For example, pharmacological activation of GABAA-receptor signaling in the hindbrain parabrachial nucleus (PBN) enhances the positive hedonic perception of tastes and foods, thereby promoting food intake and motivational response to food reward (Berridge, 2009; Cooper, 2005; Peciña and Berridge, 1996; Berridge and Peciña, 1995; Higgs and Cooper, 1996; Söderpalm and Berridge, 2000; Berridge and Treit, 1986). Utilizing advanced genetic techniques, we have shown that GABAergic signaling from AgRP neurons plays a bidirectional, post-developmental role in the regulation of food intake and body weight (Meng et al., 2016). Our recent work shows that the α5-containing GABAA receptor signaling within the bed nucleus of the stria terminalis neurons reciprocally regulates mental disorders and obesity, implying that GABAA-receptor signaling exerts a role in controlling obesity and comorbid diseases (Xia et al., 2021). In this report, we examined the neural-circuit mechanism underlying leptin action upon the AgRP neurons using a newly established and robust method of rapid inactivation of LepR signaling within AgRP neurons (Meng et al., 2016). We found that the LepR in AgRP neurons plays a pivotal role in the control of obesity and glucose homeostasis. Moreover, a subset of leptin-responsive AgRP neurons send GABAergic projections to a group of α3-containing GABAA-expressing neurons in the DMH for regulation of leptin-mediated metabolic homeostasis. These findings suggest that the identification of key GABAA signaling pathways within the post-synaptic target of a novel leptin-responsive GABAergic neural circuit forebode more efficient treatments for obesity. Results To test the role of LepR in AgRP neurons, we applied our newly developed conditional knockout approach by generating two different lines of mice: AgrpnsCre/+::Leprlox/lox::NeoR::Rosa26fs-tdTomato mice, termed the knockout group (Agrp-Lepr KO), and Agrp+/+::Leprlox/lox::NeoR::Rosa26fs-tdTomato mice, termed the control group (Meng et al., 2016). Immunohistochemistry and qPCR results showed the expression of tdTomato and deletion of Lepr in AgRP neurons 4 days after treatment of NB124, a synthetic nonsense-suppressor that can rapidly restore the function of Cre recombinase within the AgRP neurons (Figure 1A–F and Figure 1—figure supplement 1). Agrp-Lepr KO mice showed a significant increase in feeding and body weight one week after deletion of LepR signaling from AgRP neurons (Figure 1G and H). As a recapitulation of the severe hyperphagia caused by CRISPR-mediated LepR deletion (Xu et al., 2018), our Agrp-Lepr KO mice exhibited 44.5% increase in feeding as compared to the control mice. Furthermore, along with the increase of body weight and food intake, Agrp-Lepr KO mice exhibited impaired glucose tolerance (Figure 1I). Leptin induces phosphorylation of signal transducer and activator of transcription 3 (pSTAT3). pSTAT3 staining in the ARC showed enhanced extent in control mice but not in Agrp-Lepr KO mice 1 hr after leptin treatment in overnight fasted mice (Figure 1—figure supplement 2), indicating the role of leptin in the ARC was ablated. No significant changes of pSTAT3 level were observed in the DMH and VMH of control and Agrp-Lepr KO mice (Figure 1—figure supplement 3). Intriguingly, chronic infusion of bicuculline (Bic, 1 ng, a GABAA receptor antagonist) into the 3rd ventricle abolished the hyperphagia responses in Agrp-Lepr KO mice (Figure 1J), suggesting that facilitating the post-synaptic GABAA signaling to the AgRP neural circuit is important in regulating leptin-mediated feeding. The feeding efficiency (body weight gain [mg]/kilocalorie consumed) was significantly higher in Agrp-Lepr KO mice but was rescued by infusion of Bic (Figure 1K). The expansion of white adipose tissue (WAT) was observed in Agrp-Lepr KO mice (Figure 1L). We observed a significant decrease in respiratory quotient (RQ) from the Agrp-Lepr KO mice that can be further normalized by infusion of GABAA antagonist (Figure 1M). In line with other studies, these results suggest that GABA is a crucial signaling molecule by which AgRP neurons control adiposity and nutrient utilization (Wu et al., 2009; Wu et al., 2008a; Tong et al., 2008). The control and Agrp-Lepr KO mice were also analyzed for their glucose tolerance. Ablation of LepR in the AgRP neurons impaired glucose tolerance, which was fully restored by infusion of GABAA antagonist (Figure 1N). These results indicate that leptin regulates feeding and energy metabolism via post-synaptic GABAA signaling from AgRP neurons. Figure 1 with 3 supplements see all Download asset Open asset Suppressing GABAA signaling reverses feeding and metabolic dysfunction induced by leptin deficiency in AgRP neurons. (A,B) Expression of tdTomato in the arcuate nucleus with injection of NB124 into the 3rd ventricle for both Agrp+/+::Leprlox/lox::NeoR::Rosa26fs-tdTomato mice (control, (A)) and AgrpnsCre/+::Leprlox/lox::NeoR::Rosa26fs-tdTomato mice (Agrp-Lepr KO, (B)). Scale bar in B for A and B, 200 μm. (C–E) Colocalization of tdTomato (C) and anti-AgRP (D) in ARC. Scale bar in E for C–E, 100 μm. (F) Real-time qPCR analysis of Lepr transcript levels within the AgRP neurons of the control and Agrp-Lepr KO mice. (n=8 per group; *p<0.05). (G–I) Daily calorie intake (G) and body weight (H) of the control and Agrp::LeprKO mice. The GTT (I) was tested on the day 21 after injection of NB124. (n=8 per group; *p<0.05). (J) The 4-hr food intake by the control and Agrp-Lepr KO mice after chronic infusion of Bic (1 ng) into the 3rd ventricle for 4 weeks. (K) Feeding efficiency is presented as mg of body weight gain/kcal consumed in the mice as described in J. (L) Weight of adipose tissues in the mice as described in J (Visc WAT: visceral white adipose tissue; BAT: brown adipose tissue). (M) Average value for RQ (defined as ratio of VCO2/VO2) tested on Day 28 in the mice as described in J. (N) The GTT was performed in the mice as described in J. (n=8 per group in J–N; *p<0.05 between Control and Agrp-Lepr KO, #p<0.05 between Control and Control +Bic(i.c.v.), ‡p<0.05 between Agrp-Lepr KO and Agrp-Lepr KO +Bic(i.c.v.)). Error bars represent mean ± SEM. unpaired two-tailed t test in F; one-way ANOVA and followed by Tukey comparisons test in J–M; two-way ANOVA and followed by Bonferroni comparisons test in G–I, and N. Figure 1—source data 1 The original data of body weight, food intake, and GTT for Figure 1. https://cdn.elifesciences.org/articles/82649/elife-82649-fig1-data1-v1.xlsx Download elife-82649-fig1-data1-v1.xlsx To identify the key downstream targets of AgRP neurons that contribute to leptin-mediated responses, we examined the Npas4 expression in potential AgRP target neurons. Traditional immediate early genes are regulated by neuromodulators via cAMP, neurotrophins, and other paracrine factors, and their kinetics are relatively slow. In contrast, Npas4 has a more dynamic response to activity-dependent signaling via Ca2+, and it can be bidirectionally regulated by either excitatory or inhibitory input (Shepard et al., 2019). The qPCR results showed that rapid deletion of LepR signaling from AgRP neurons resulted in a significant decrease of Npas4 abundance within the DMH (Figure 2A). To identify the functional relevance of each downstream target to leptin signaling, we administered DT into neonatal AgrpDTR mice to ablate all AgRP neurons and examined the neural activity of their downstream targets in response to leptin (Figure 2B; Luquet et al., 2007; Zimmer et al., 2019). Without ablation of AgRP neurons, leptin induced robust Fos expression in almost all major targets of AgRP neurons (Wu et al., 2009; Wu et al., 2012; Wu et al., 2008b). However, neonatal ablation of AgRP neurons significantly diminished the leptin-mediated Fos induction within post-synaptic neurons residing in the DMH (Figure 2C–F and Figure 2—figure supplement 1). These results suggest that the DMH could be the key downstream target that critically contributes to the regulation of leptin-mediated appetitive and metabolic responses. To further visualize the neural circuit from AgRP neurons to DMH, we injected a retrograde herpes simplex virus (HSV) encoding a red fluorescent protein (HSV-hEf1α-mCherry) into the DMH of NpyGFP mice (Figure 2G). Both HSV-based retrograde tracing and cholera toxin subunit B (CTB)-based retrograde neuroanatomical tracing from the DMH showed that ~17% (CTB tracing) or 39% (HSV tracing) of AgRP neurons project to the DMH (Figure 2H–L and Figure 2—figure supplement 2). Figure 2 with 2 supplements see all Download asset Open asset Identification of downstream targets of the leptin-responsive AgRP neurons. (A) Real-time qPCR analysis of transcript levels of Npas4 expressed in the DMH, PVH, PVT, and PBN in the control and Agrp-Lepr KO mice. (n=8 per group; *p<0.05). (B) The schematic diagram showing Fos activities in downstream targets of AgRP neurons after treatment of leptin combined with or without neonatal ablation of AgRP neurons. (C–F) Expression profiling of Fos (green) in the DMH under vehicle (D), leptin (i.p.) (E), leptin (i.p.) and DT (s.c. neonates) (F). Scale bar in D for D–F, 200 μm. (n=8 per group; *p<0.05). (G) Diagram shows retrograde tracing of AgRPARC→DMH neurons by injection of HSV-hEf1α-mCherry into the DMH of NpyGFP mice. (H–K) The fluorescence in the DMH (H) and ARC (I–K, yellow, DMH-projecting AgRP neurons). Scale bar in H, 200 µm; scale bar in I for (I–K), 100 µm. (L) Quantification of overlap of HSV-hEf1α-mCherry and NPY-GFP. (n=8 per group). Error bars represent mean ± SEM; unpaired two-tailed t test in A; one-way ANOVA and followed by Tukey comparisons test in C. Figure 2—source data 1 The histological data for Figure 2. https://cdn.elifesciences.org/articles/82649/elife-82649-fig2-data1-v1.xlsx Download elife-82649-fig2-data1-v1.xlsx To establish a role of the DMH within the leptin-responsive AgRP neural circuit, we combined the transsynaptic tracer (WGA-ZsGreen) and whole-cell, patch-clamp recordings to facilitate electrophysiological analysis of neurons in the DMH that are innervated by AgRP neurons (Figure 3A and B; Han et al., 2021b; Han et al., 2021a; Xu et al., 2017; Xia et al., 2021). RNA in situ hybridization confirmed that ~78% of AgRP-targeted neurons in the DMH express melanocortin receptor 4 (MC4R) (Figure 3C and Figure 3—figure supplement 1). To test whether this connectivity was monosynaptic, we perfused tetrodotoxin (TTX) and 4-aminopyridine (4-AP) into the bath to remove any network activity. We observed that inhibitory postsynaptic currents (IPSCs) in the DMH neurons triggered by photostimulation of ChR2-expressing axonal terminals of AgRP neurons were fully blocked by Bic (Figure 3D and E), confirming that these terminals were releasing GABA. In the presence of DNQX (a competitive AMPA/kainate receptor antagonist), AP5 (a selective NMDA receptor antagonist) and Bic, photostimulation of the ChR2-expressing AgRP terminals resulted in inhibition of action potentials in postsynaptic ZsGreen-positive neurons of the DMH in a reversible manner with significant reduction of firing rate and resting membrane potential (Figure 3F–I). We further examined the effect of leptin on the firing of postsynaptic ZsGreen-positive neurons in the DMH. We found that systemic treatment of leptin significantly enhanced neural activities of DMH neurons (Figure 3J and K). Figure 3 with 1 supplement see all Download asset Open asset Leptin-responsive AgRP neurons directly innervate DMH neurons. (A) Diagram of transsynaptic tracing downstream targets from AgRP neurons. AAV9-DIO-WGA-ZsGreen, a Cre-dependent tracer that labels neurons with synaptic connections, was injected into the ARC of AgrpCre::Ai32 mice. Ai32 mice express ChR2/EYFP fusion protein conditioned Cre-mediated recombination. (B) ChR2-EYFP-labeled AgRP neurons in the ARC. Scale bar, 200 μm. (C) Double-labeling of MC4R neurons with transsynaptic WGA-ZsGreen in the DMH (C), green, ZsGreen RNA in situ; red, Mc4r RNA in situ. Scale bar, 100 μm. (D) The response of IPSCs recorded from an ZsGreen+ neuron upon photostimulation of AgRP terminals within the DMH (10ms pulse) with a pretreatment of vehicle or TTX +4 AP, and in slices pretreated with either TTX +4 AP or TTX +4-AP+Bic. (E) Statistical amplitude analysis of IPSCs from neurons recorded in D. (n=7 neurons; *p<0.05 between TTX +4 AP and TTX +4-AP+Bic). (F) Representative spikes of ZsGreen-labeled DMH neurons before and after blue light pulses (20ms/pulse, 20 Hz) shined onto AgRP axonal fibers. (G–I) Firing frequency (G), resting membrane (H), and statistical analysis (I) of neurons recorded in F (n=7 neurons; *p<0.05). (J,K) Firing frequency (J), and resting membrane (K) of ZsGreen-labeled DMH neurons with or without leptin i.p. treatment. (n=7 neurons; *p<0.05). Error bars represent mean ± SEM. paired two-tailed t test in G,H, J, and K; one-way ANOVA and followed by Tukey comparisons test in E. Figure 3—source data 1 The original data of firing rate and rest membrane potential from in vitro electrophysiological recording in Figure 3. https://cdn.elifesciences.org/articles/82649/elife-82649-fig3-data1-v1.xlsx Download elife-82649-fig3-data1-v1.xlsx To examine the role of the AgRP→DMH circuit in the regulation of feeding and glucose, we performed optogenetic manipulation in AgrpCre::Roas26fs-ChR2 (Ai32) mice where ChR2-EYFP was selectively expressed in AgRP neurons and axonal terminals (Han et al., 2021b; Xia et al., 2021). Photostimulation of AgRP fibers in the DMH promoted feeding and impaired glucose tolerance (Figure 4A and B). We found that about 13% of DMH neurons could be sensitive to the activation of AgRP neurons (Figure 4—figure supplement 1). We did not observe significant changes of Fos expression in the ARC after activation of AgRP fiber in the DMH, which excludes the potential effects of activating AgRP neurons (Figure 4—figure supplement 1D, H and J). In contrast, photostimulation of post-synaptic MC4RDMH neurons decreased feeding and improved glucose tolerance (Figure 4C and D). Bilateral infusion of Bic (4 ng) into the DMH of Agrp-Lepr KO mice with micro-osmotic pumps resulted in reduced feeding and a significant reduction of body weight, coupled with improved glucose tolerance (Figure 4E–G). Blockage of GABAA receptor in the DMH significantly rescued the feeding efficiency, expansion of WAT, and the RQ profiles in Agrp-Lepr KO mice (Figure 4H–K). The effect of drug diffusion was examined by Fos expression in the DMH and the neighboring brain regions, showing no significant difference of Fos expression in these regions. (Figure 4—figure supplement 2). These results suggest that GABAA receptor signaling in the DMH is critical for the feeding, body weight, and glucose tolerance regulated by LepR in AgRP neurons. Figure 4 with 2 supplements see all Download asset Open asset The leptin-responsive AgRP-DMH circuit regulates feeding, body weight, and glucose tolerance. (A,B) 1-hr food intake (A) and GTT (B) after photostimulation of the AgRP→DMH circuit. (n=8 per group; *p<0.05). (C,D) 1-hr refeeding test (C) and GTT (D) after photostimulation of the MC4RDMH neurons. (n=8 per group; *p<0.05). (E–G) Daily food intake (E), body weight (F) and GTT (G) in control mice, Agrp-Lepr KO mice with Bic or vehicle injected into the DMH. The saline or Bic (4 ng; 0.25 μl/hr) was chronically infused into the DMH via the osmotic minipump for 14 days. (n=8 per group; *p<0.05 between Control and Agrp-Lepr KO, #p<0.05 between Agrp-Lepr KO and Agrp-Lepr KO +Bic(DMH), ‡p<0.05 between Control and Control +Bic(DMH)). (H) 4-hr food intake in the mice described in E-G on day 14. (I) Feed efficiency in the mice described in E–G. (J) Weight of adipose tissues in the mice described in E–G on day 14. (K) Average value for RQ (VCO2/VO2) in the mice described in E–G on day 14. (n=8 per group in H–K; *p<0.05 between Control and Agrp-Lepr KO, #p<0.05 between Agrp-Lepr KO and Agrp-Lepr KO +Bic(DMH)). (L–O) Firing rate of representative MC4RDMH neurons and non-MC4RDMH neurons when mice under baseline (satiation) (L, N), foraging (prior to meal initiation) (M), and glucose i.p. injection (well-fed state) (O). The statistical analysis of the firing rate under baseline, foraging (P), and glucose treatment (Q) were calculated. (n=10 neurons from 3 mice in each group; *p<0.05). Error bars represent mean ± SEM. unpaired two-tailed t test in A, C, P and Q; one-way ANOVA and followed by Tukey comparisons test in H–K; two-way ANOVA and followed by Bonferroni comparisons test in B and D–G. Figure 4—source data 1 The original data of body weight, food intake, GTT, and firing rate of MC4R neurons in the DMH for Figure 4. https://cdn.elifesciences.org/articles/82649/elife-82649-fig4-data1-v1.xlsx Download elife-82649-fig4-data1-v1.xlsx To better understand the physiological responses of these GABAergic neurons in the context of feeding and glucose regulation, we employed an in vivo opto-tetrode system to reveal the dynamic activities of MC4RDMH neurons (Han et al., 2021a). With the injection of AAV2-DIO-ChR2-GFP into the DMH of Mc4rCre mice, we could record the activity of DMH neurons and identify those that express MC4R by their short-latency response to photostimulation as well as by the identical waveforms of evoked and spontaneous spikes (Han et al., 2021a). We investigated the activities of MC4RDMH neurons and non-MC4RDMH neurons under chow diet and hyperglycemia conditions. A total of 16 MC4RDMH neurons and 12 non-MC4RDMH neurons were identified through optogenetic-invoked spikes. The results showed that 10 out of 16 identified MC4R neurons showed decreased firing rate during foraging (prior to meal initiation), with an average reduction of firing rate from 9.8 Hz to 5.1 Hz (Figure 4L, M and P). We also observed 10 out of 16 MC4R neurons that responded to the enhancement of blood glucose with a reduction of firing rate from 10.0 Hz to 7.1 Hz (Figure 4N, O and Q). These results are consistent with MC4RDMH neurons’ mediation of foraging and glucose tolerance. Our results showed that GABAA receptors in the DMH are involved in the regulation of feeding and glucose tolerance; thus, we attempted to identify the key GABAA receptor subunits that are functionally relevant to glucose and feeding regulation. Results of qPCR analysis showed that, among all major regulatory α subunits, the transcript level of Gabra3 (encoding GABAA receptor α3 subunits) in the DMH neurons of Agrp-Lepr KO mice was the highest (Figure 5A). Immunostaining confirmed that α3-GABAA was abundantly expressed within the DMH (Figure 5B). Our transsynaptic tracing study further confirmed that the α3-GABAA signaling was highly co-localized within the post-synaptic targets of the AgRP→DMH neural circuit (Figure 5C–E). To understand the functional roles of α3-GABAA signaling within DMH neurons for leptin-mediated feeding and glucose, Mc4rCre::Rosa26fs-Cas9 mice were injected with AAV9-Gabra3sgRNA-tdTomato into the DMH. We found that knockout of Gabra3 signaling in the MC4RDMH neurons reduced feeding and body weight while glucose tolerance was significantly improved (Figure 5F–H and Figure 5—figure supplement 1). Deficiency in α3-GABAA signaling also significantly decreased feeding efficiency and WAT (Figure 5I and J). A gain-of-function study showed that overexpression of α3-GABAA within the same MC4RDMH neurons manifested opposite phenotypes, including moderately increased feeding and body weight and significantly increased feeding efficiency and WAT adiposity (Figure 5F–J). Importantly, overexpression of α3-GABAA in the DMH neurons blunted the actions of leptin on feeding, body weight, glucose tolerance, feeding efficiency, and WAT adiposity (Figure 5K–O). To determine the role of α3-GABAA receptor signaling from the MC4RDMH neurons in the regulation of feeding and glucose tolerance by activation of AgRP-DMH circuit, NpyFlp::Mc4Cre mice with were injected with AAV9-fDIO-ChR2-EYFP into the ARC, AAV9-DIO-Cas9-mCitrine and AAV9-Gabra3sgRNA-tdTomato into the DMH of followed with implantation of optic fiber in the DMH. We found that knockout of Gabra3 signaling in the MC4RDMH neurons abolished the enhancement of feeding and impairment of glucose tolerance during activation of AgRP-DMH circuit (Figure 5—figure supplement 2). These results suggest the AgRP-DMH circuit regulates feeding and glucose tolerance depending on the α3-GABAA receptor signaling in the MC4RDMH neurons. We further examined the effects of ablating α3-GABAA in the DMH on feeding and body weight in diet-induced obese mice. We found that genetic deletion of Gabra3 signaling in the MC4RDMH neurons led to a decrease in daily food consumption associated with a moderate weight loss and that these knockout mice showed reduced refeeding responses (Figure 5P–R). These results suggest that the MC4RDMH neurons play a significant role in control of glucose tolerance and feeding through the α3-GABAA signaling. Figure 5 with 2 supplements see all Download asset Open asset The α3-GABAA receptor signaling within the MC4RDMH mediates feeding and glucose tolerance. (A) Expression level of Gabra1- Gabra6 in the DMH neurons of control and Agrp-Lepr KO mice. (B) Immunostaining showing the expression of GABAA α3 in the DMH. Scale bar, 100 μm. (C–E) Colocalization of GABAA α3 and transsynaptically labeled neurons by WGA-ZsGreen in the DMH after injection of AAV9-DIO-WGA-ZsGreen into the ARC of AgrpCremice. Scale bar in E for C–E, 50 μm. (F–H) The food intake (F), body weight (G), and GTT (H) were performed in Mc4rCre::Rosa26fs-Cas9 mice with a bilateral injection of vehicle, AAV9-Gabra3sgRNA-tdTomato (GABAA-α3 KO), or AAV9-DIO-Gabra3cDNA-EYFP (GABAA-α3 OE) into the DMH. (I) Feeding efficiency in the mice described in F–H. (J) Weight of adipose tissues in the mice described in F–H. n=8 per group in F–J; *p<0.05 between Control and GABAA-α3 KO, #p<0.05 between Control and GABAA-α3 OE. (K–O) The food intake (K), body weight (L), GTT (M), feeding efficiency (N), and weight of adipose tissues (O) were performed in control mice and GABAA-α3 OE mice followed by the microinjection of leptin into ARC. (n=8 per group in K-O; *p<0.05 between Control +leptin and GABAA-α3 OE +leptin). (P–R) The 24-hr food intake (P), body weight change (Q), and refeeding test (R) were performed in HFD-treated with or without knockout of GABAA-α3. (n=8 per group; *p<0.05). Error bars represent mean ± SEM. unpaired two-tailed t test in A and N–R; one-way ANOVA and followed by Tukey comparisons test in I and J; two-way ANOVA and followed by Bonferroni comparisons test in F–H and K–M. (S) Diagram showing a leptin regulated GABAergic neural circuit reverses obesity. The GABAergic AgRPLepR→DMH circuit plays a critical role in control of leptin-mediated food intake, body weight, and glucose tolerance through the α3-GABAA signaling within the MC4RDMH neurons. Figure 5—source data 1 The original data of body weight, food intake, and GTT for Figure 5. https://cdn.elifesciences.org/articles/82649/elife-82649-fig5-data1-v1.xlsx Download elife-82649-fig5-data1-v1.xlsx Discussion Leptin exerts its behavioral and metabolic effects by modulating signaling of AgRP neurons that are susceptible to obesity-induced lep